HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

New drugs and new targets.

Abstract
At the 8th World Congress on Clinical Pharmacology and Therapeutics, held August 1-6, 2004, in Queensland, Australia, there were late-breaking news symposia on presynaptic receptors as targets in the treatment of schizophrenia; cyclooxygenase inhibition, present and future; adiposity, drug treatment and causes; G-protein-coupled receptors, important new targets; osteoporosis, causes, prevention and cures; ischemic stroke; drugs and arrhythmias, causes and cures; and the pharmacology of cardiac protection. One of the plenary lectures was of targeted cancer therapies. The new drugs and new targets for therapeutic intervention from these presentations are discussed in this report.
AuthorsSheila A Doggrell
JournalDrug news & perspectives (Drug News Perspect) Vol. 17 Issue 9 Pg. 615-32 (Nov 2004) ISSN: 0214-0934 [Print] United States
PMID15645019 (Publication Type: Congress)
CopyrightCopyright 2004 Prous Science. All rights reserved.
Chemical References
  • Antineoplastic Agents
  • Cyclooxygenase Inhibitors
  • Receptors, G-Protein-Coupled
  • Receptors, Presynaptic
  • NADPH Oxidases
Topics
  • Antineoplastic Agents (chemistry, supply & distribution, therapeutic use)
  • Audiovisual Aids
  • Australia
  • Cyclooxygenase Inhibitors (chemistry, therapeutic use)
  • Drug Delivery Systems (methods, trends)
  • Drug Design
  • Humans
  • Hypertension (drug therapy, etiology, prevention & control)
  • Long QT Syndrome (chemically induced, drug therapy)
  • Myocardial Ischemia (drug therapy, physiopathology)
  • NADPH Oxidases (antagonists & inhibitors, therapeutic use)
  • Obesity (drug therapy, etiology)
  • Osteoporosis (drug therapy, etiology, prevention & control)
  • Pharmacists (organization & administration, trends)
  • Pharmacogenetics (trends)
  • Pharmacology, Clinical (organization & administration, trends)
  • Receptors, G-Protein-Coupled (drug effects, therapeutic use)
  • Receptors, Presynaptic (drug effects, therapeutic use)
  • Schizophrenia (drug therapy)
  • Societies, Scientific (organization & administration)
  • Stroke (drug therapy, epidemiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: